Puri Kriti, Jentzer Jacob C, Spinner Joseph A, Hope Kyle D, Adachi Iki, Tume Sebastian C, Tunuguntla Hari P, Choudhry Swati, Cabrera Antonio G, Price Jack F
Lillie Frank Abercrombie Division of Pediatric Cardiology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA; Division of Pediatric Critical Care Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
J Am Coll Cardiol. 2024 Feb 6;83(5):595-608. doi: 10.1016/j.jacc.2023.11.019.
Despite growing cardiogenic shock (CS) research in adults, the epidemiology, clinical features, and outcomes of children with CS are lacking.
This study sought to describe the epidemiology, clinical presentation, hospital course, risk factors, and outcomes of CS among children hospitalized for acute decompensated heart failure (ADHF).
We examined consecutive ADHF hospitalizations (<21 years of age) from a large single-center retrospective cohort. Patients with CS at presentation were analyzed and risk factors for CS and for the primary outcome of in-hospital mortality were identified. A modified Society for Cardiovascular Angiography and Interventions shock classification was created and patients were staged accordingly.
A total of 803 hospitalizations for ADHF were identified in 591 unique patients (median age 7.6 years). CS occurred in 207 (26%) hospitalizations. ADHF hospitalizations with CS were characterized by worse systolic function (P = 0.040), higher B-type natriuretic peptide concentration (P = 0.032), and more frequent early severe renal (P = 0.023) and liver (P < 0.001) injury than those without CS. Children presenting in CS received mechanical ventilation (87% vs 26%) and mechanical circulatory support (45% vs 16%) more frequently (both P < 0.001). Analyzing only the most recent ADHF hospitalization, children with CS were at increased risk of in-hospital mortality compared with children without CS (28% vs 11%; OR: 1.91; 95% CI: 1.05-3.45; P = 0.033). Each higher CS stage was associated with greater inpatient mortality (OR: 2.40-8.90; all P < 0.001).
CS occurs in 26% of pediatric hospitalizations for ADHF and is independently associated with hospital mortality. A modified Society for Cardiovascular Angiography and Interventions classification for CS severity showed robust association with increasing mortality.
尽管成人的心源性休克(CS)研究日益增多,但儿童CS的流行病学、临床特征和转归情况仍不明确。
本研究旨在描述因急性失代偿性心力衰竭(ADHF)住院的儿童CS的流行病学、临床表现、住院病程、危险因素及转归。
我们对一个大型单中心回顾性队列中连续的ADHF住院病例(年龄<21岁)进行了研究。对入院时患有CS的患者进行分析,确定CS及院内死亡这一主要结局的危险因素。创建了改良的心血管造影和介入学会休克分类,并据此对患者进行分期。
共确定了591例独特患者的803次ADHF住院病例(中位年龄7.6岁)。207次(26%)住院病例发生了CS。与无CS的ADHF住院病例相比,伴有CS的ADHF住院病例的收缩功能更差(P = 0.040)、B型利钠肽浓度更高(P = 0.032),早期严重肾脏损伤(P = 0.023)和肝脏损伤(P < 0.001)更常见。出现CS的儿童接受机械通气(87%对26%)和机械循环支持(45%对16%)的频率更高(P均< 0.001)。仅分析最近一次ADHF住院病例,与无CS的儿童相比,患有CS的儿童院内死亡风险增加(分别为28%和11%;OR:1.91;95%CI:1.05 - 3.45;P = 0.033)。CS分期越高,住院死亡率越高(OR:2.40 - 8.90;所有P < 0.001)。
26%的ADHF儿童住院病例发生CS,且与院内死亡独立相关。改良的心血管造影和介入学会CS严重程度分类与死亡率增加密切相关。